CDR2L antibody (N-Term)
Quick Overview for CDR2L antibody (N-Term) (ABIN2780937)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- MRRAAGMEDF SAEEEESWYD QQDLEQDLHL AAELGKTLLE RNKELEGSLQ
-
Predicted Reactivity
- Cow: 93%, Dog: 93%, Guinea Pig: 93%, Horse: 93%, Human: 100%, Mouse: 93%, Rat: 93%, Zebrafish: 86%
-
Characteristics
- This is a rabbit polyclonal antibody against CDR2L. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human CDR2L
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 465 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- CDR2L (Cerebellar Degeneration-Related Protein 2-Like (CDR2L))
-
Alternative Name
- CDR2L
-
Background
-
The function of CDR2L remains unknown.
Alias Symbols: HUMPPA
Protein Interaction Partner: ELAVL1,
Protein Size: 465 -
Molecular Weight
- 53 kDa
-
Gene ID
- 30850
-
NCBI Accession
- NM_014603, NP_055418
-
UniProt
- Q86X02
Target
-